These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 31132643)
1. Hypoxia-targeting dendritic MRI contrast agent based on internally hydroxy dendrimer for tumor imaging. Han Y; Zhou X; Qian Y; Hu H; Zhou Z; Liu X; Tang J; Shen Y Biomaterials; 2019 Aug; 213():119195. PubMed ID: 31132643 [TBL] [Abstract][Full Text] [Related]
2. Zwitterionic Gadolinium(III)-Complexed Dendrimer-Entrapped Gold Nanoparticles for Enhanced Computed Tomography/Magnetic Resonance Imaging of Lung Cancer Metastasis. Liu J; Xiong Z; Zhang J; Peng C; Klajnert-Maculewicz B; Shen M; Shi X ACS Appl Mater Interfaces; 2019 May; 11(17):15212-15221. PubMed ID: 30964632 [TBL] [Abstract][Full Text] [Related]
3. Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent. Han L; Li J; Huang S; Huang R; Liu S; Hu X; Yi P; Shan D; Wang X; Lei H; Jiang C Biomaterials; 2011 Apr; 32(11):2989-98. PubMed ID: 21277017 [TBL] [Abstract][Full Text] [Related]
4. Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. Xu H; Regino CA; Koyama Y; Hama Y; Gunn AJ; Bernardo M; Kobayashi H; Choyke PL; Brechbiel MW Bioconjug Chem; 2007; 18(5):1474-82. PubMed ID: 17711320 [TBL] [Abstract][Full Text] [Related]
5. Targeted biodegradable dendritic MRI contrast agent for enhanced tumor imaging. Ye M; Qian Y; Tang J; Hu H; Sui M; Shen Y J Control Release; 2013 Aug; 169(3):239-45. PubMed ID: 23403397 [TBL] [Abstract][Full Text] [Related]
6. Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging. Gündüz S; Savić T; Toljić Đ; Angelovski G J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060285 [TBL] [Abstract][Full Text] [Related]
7. Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor. Wiener EC; Konda S; Shadron A; Brechbiel M; Gansow O Invest Radiol; 1997 Dec; 32(12):748-54. PubMed ID: 9406015 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of Chiral Dendrimer-Triamine-Coordinated Gd-MRI Contrast Agents Evaluated by in Vivo MRI and Estimated by in Vitro QCM. Miyake Y; Ishikawa S; Kimura Y; Son A; Imai H; Matsuda T; Yamada H; Toshimitsu A; Kondo T Sensors (Basel); 2015 Dec; 15(12):31973-86. PubMed ID: 26694418 [TBL] [Abstract][Full Text] [Related]
9. Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly(β-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies. Mortezazadeh T; Gholibegloo E; Alam NR; Dehghani S; Haghgoo S; Ghanaati H; Khoobi M MAGMA; 2019 Aug; 32(4):487-500. PubMed ID: 30730021 [TBL] [Abstract][Full Text] [Related]
10. Gadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agents. Luo K; Liu G; She W; Wang Q; Wang G; He B; Ai H; Gong Q; Song B; Gu Z Biomaterials; 2011 Nov; 32(31):7951-60. PubMed ID: 21784511 [TBL] [Abstract][Full Text] [Related]
12. Biodegradable Nanoglobular Magnetic Resonance Imaging Contrast Agent Constructed with Host-Guest Self-Assembly for Tumor-Targeted Imaging. Cao Y; Zu G; Kuang Y; He Y; Mao Z; Liu M; Xiong D; Pei R ACS Appl Mater Interfaces; 2018 Aug; 10(32):26906-26916. PubMed ID: 30028584 [TBL] [Abstract][Full Text] [Related]
13. Facile Synthesis of Gadolinium Chelate-Conjugated Polymer Nanoparticles for Fluorescence/Magnetic Resonance Dual-Modal Imaging. Pan Y; Chen W; Yang J; Zheng J; Yang M; Yi C Anal Chem; 2018 Feb; 90(3):1992-2000. PubMed ID: 29293314 [TBL] [Abstract][Full Text] [Related]
15. Multifunctional gadolinium-based dendritic macromolecules as liver targeting imaging probes. Luo K; Liu G; He B; Wu Y; Gong Q; Song B; Ai H; Gu Z Biomaterials; 2011 Apr; 32(10):2575-85. PubMed ID: 21256587 [TBL] [Abstract][Full Text] [Related]
16. Chlorotoxin-modified macromolecular contrast agent for MRI tumor diagnosis. Huang R; Han L; Li J; Liu S; Shao K; Kuang Y; Hu X; Wang X; Lei H; Jiang C Biomaterials; 2011 Aug; 32(22):5177-86. PubMed ID: 21531455 [TBL] [Abstract][Full Text] [Related]
17. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. Kobayashi H; Kawamoto S; Jo SK; Bryant HL; Brechbiel MW; Star RA Bioconjug Chem; 2003; 14(2):388-94. PubMed ID: 12643749 [TBL] [Abstract][Full Text] [Related]
18. Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer. Khantasup K; Saiviroonporn P; Jarussophon S; Chantima W; Dharakul T MAGMA; 2018 Oct; 31(5):633-644. PubMed ID: 29737435 [TBL] [Abstract][Full Text] [Related]
19. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model. Chen WT; Shih TT; Chen RC; Tu SY; Hsieh WY; Yang PC Mol Imaging; 2012; 11(4):286-300. PubMed ID: 22954145 [TBL] [Abstract][Full Text] [Related]